Clinical trials
Ventricular Assist Device clinical trials
Below are recruiting ventricular assist device clinical trials, each written for real people, not researchers. We’re tracking 36 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06637644Recruiting
Impella RP Flex device registry
This registry collects information about people who have used the Impella RP Flex device, a heart pump that helps support blood flow. Your data will help doctors learn more about how this device works in real-world patients.
Birmingham, AlabamaAges Any age - NCT06823583Recruiting
VAD guidance tool testing for patients and clinicians
This study tests a new tool that helps patients prepare for getting a ventricular assist device (VAD), a machine that helps the heart pump blood. Researchers want to see if the tool is easy to use and helpful for both patients and their doctors.
Lincoln, NebraskaAges 19 years+ - NCT07053618Recruiting
Heart pump support for high-risk heart procedures
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
Beijing, Beijing MunicipalityAges 18–90 - NCT06039176Recruiting
Learning from the HeartMate 3 device
This study looks at information from the HeartMate 3 LVAD device to learn more about how it works and what it can tell us about the future. It may help people with advanced heart failure who need this specific device.
San Francisco, CaliforniaAges 18–100 - NCT06464016Recruiting
Infections in Kids With Berlin Heart Pumps
This study looks at infections in children who used a Berlin Heart mechanical heart pump. It aims to find better ways to prevent and treat these infections.
LyonAges 1 day–18 years - NCT06867887Enrolling by invitation
Finding LVAD driveline infections with your smartphone
This trial tests a way to find infections where the LVAD driveline enters your body, using just your smartphone camera. If you have an LVAD, you might be able to join and help researchers see if this simple method works.
RotterdamAges 16–99 - NCT04377854Recruiting
Checking whether BNP predicts outcomes in advanced heart failure
This study looks at whether a blood test called BNP can help predict what happens over time in people being evaluated for advanced heart failure treatment. It may help doctors better plan care and follow-up for patients long-term.
Copenhagen, DKAges 18 years+ - NCT05034432RecruitingPhase 4
Test treatment for dangerous heart rhythm episodes in LVAD patients
This trial studies a procedure to fix abnormal heart rhythms (ventricular tachycardia or ventricular fibrillation) in people who have an LVAD and a defibrillator (ICD) or an alternative device. It may help prevent future dangerous rhythm episodes after LVAD treatment.
Phoenix, ArizonaAges 18 years+ - NCT06556485Recruiting
Early ablation for heart failure patients with heart pumps or on transplant list
This trial tests whether doing a catheter ablation early (before dangerous heart rhythms start) can help people with severe heart failure who need a heart transplant or already have an ICD. The goal is to see if this can improve outcomes.
Bad OeynhausenAges 18–99 - NCT07034599Recruiting
Negative pressure breathing after heart pump implant
This study looks at how a breathing machine that uses negative pressure (like a vacuum) affects the heart and blood flow in people who have a left ventricular assist device (LVAD), a type of heart pump. It may help doctors learn the best way to support breathing after surgery.
KarlsburgAges 18 years+ - NCT03255928Recruiting
Study blood clot cell activity in people with a heart pump
This study looks at how your blood’s clot-forming cells (platelets) behave when you have a heart pump device placed (short-term or long-term). The results may help doctors better understand complications and how to manage them after implantation.
Milan, MIAges 18–75 - NCT07497308Recruiting
GDF-15 levels and early outcomes after LVAD surgery
This trial looks at a blood marker called GDF-15 in people getting a heart pump (LVAD) to see if it can help predict early recovery or complications. It may help doctors better understand how patients will do after surgery.
Antalya, Please Select:Ages 18 years+ - NCT07382284Recruiting
Long-term survival after LVAD for end-stage heart failure
This trial looks at how well people with advanced heart failure do over the long term after getting a left-ventricular assist device (LVAD). Researchers will check blood and heart tissue samples to learn more about recovery and outcomes.
Nanjing, JiangsuAges Any age - NCT05271214Recruiting
Testing conservative care for people with failing heart pumps
This trial is studying a non-surgical (conservative) treatment approach for people being considered for a left ventricular assist device (LVAD). It may help some patients who are too sick or unable to tolerate standard heart failure medicines, but it will only match people with specific heart function and health-test results.
Tel AvivAges 18–80 - NCT06988995Recruiting
Compassion support study for LVAD patients and caregivers
This study tests a compassion-based support program for people with a left ventricular assist device (LVAD) and their family caregivers. It aims to improve emotional well-being and reduce distress.
Gainesville, FloridaAges 18–80 - NCT05366452Recruiting
Early heart pump implant for shock after a heart attack
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
Marseille, Bouche DU RhoneAges 18–80 - NCT06154044RecruitingPhase 2
Cell therapy for heart recovery with LVAD support
This trial tests whether injecting special cells (cell therapy) can help the heart recover in people with advanced heart failure who are getting a mechanical heart pump (LVAD). It may offer a new way to improve heart function and quality of life.
LjubljanaAges 18–65 - NCT06291922Recruiting
Home exercise program for LVAD recovery
This study tests a home exercise program using your smartphone after you get a HeartMate 3™ LVAD. It aims to help you get stronger and recover safely at home.
Detroit, MichiganAges 18 years+ - NCT06510322RecruitingEarly Phase 1
Sildenafil for LVAD support
This trial tests whether sildenafil (the drug in Viagra) can help reduce blood vessel changes in people with a left ventricular assist device (LVAD). It aims to improve heart-pump function and overall health.
The Bronx, New YorkAges 18 years+ - NCT07096973Recruiting
Heart rehab recovery study in Davos
This study looks at how people recover during heart rehabilitation at a clinic in Davos. By tracking your progress, researchers hope to learn what helps people get better.
Davos, Kanton GraubündenAges 18 years+ - NCT02537769Recruiting
Surgery to fix a leaky tricuspid valve in LVAD patients
This study looks at whether fixing a mildly leaky tricuspid valve during LVAD surgery improves outcomes for people with advanced heart failure. It’s mainly aimed at patients who are already scheduled to receive an implantable LVAD.
Seattle, WashingtonAges 18 years+ - NCT05388019Enrolling by invitation
VAD clinic visit study for new and returning patients
This trial looks at how well a specialized, multidisciplinary clinic works for people who have a ventricular assist device (VAD) and compares new VAD patients with those who have already had standard follow-up visits. It may help improve how care and check-ins are organized after your VAD is implanted.
Boston, MassachusettsAges 18 years+ - NCT06127927Recruiting
Heart pump for severe heart failure
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
Fuzhou, FujianAges 18–75 - NCT07704424Recruiting
Testing a heart pump for severe right heart failure
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
Hefei, AnhuiAges 18 years+
Hear when a new Ventricular Assist Device trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ventricular assist device?
- Yes. Clin2 currently lists 36 recruiting ventricular assist device studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ventricular assist device trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ventricular assist device trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.